|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received November 15, 2007
Revised December 29, 2007
Accepted after revision January 25, 2008
1 University of Texas Health Science Center
* To whom correspondence should be addressed. E-mail: shapirom{at}uthscsa.edu.
Neural M-type (KCNQ/Kv7) K+ channels control somatic excitability, bursting and neurotransmitter release throughout the nervous system. Their activity is regulated by multiple signaling pathways. In superior cervical ganglion sympathetic neurons, muscarinic M1, angiotensin II AT1, bradykinin B2 and purinergic P2Y agonists suppress M current (IM). Probes of PLC activity show agonists of all four receptors to induce robust PIP2 hydrolysis. We have grouped these receptors into two related modes of action. One mode involves depletion of phosphatidylinositol 4,5-bisphosphate (PIP2) in the membrane, whose interaction with the channels is thought necessary for their function. The other involves IP3-mediated intracellular Ca2+ signals that stimulate PIP2 synthesis, preventing its depletion, and suppress IM via calmodulin. Carbon-fiber amperometry can evaluate the effect of M-channel activity on release of neurotransmitter. Consistent with the dominant role of M current in control of neuronal discharge, M-channel openers, or blockers, reduced or augmented the evoked release of norepinephrine neurotransmitter from SCG neurons, respectively. We seek to localize the sub-domains on the channels critical to their regulation by PIP2. Based on single-channel recordings from chimeras between high-PIP2 affinity KCNQ3 and low-PIP2 affinity KCNQ4 channels, we focus on a 57-residue domain within the carboxy-terminus that is a possible PIP2 binding site. Homology modeling of this linker region using the published structure of IRK1 channels as a template predicts a structure very similar to an analogous region in IRK1 channels, and show a cluster of basic residues in the KCNQ2 domain to correspond to those implicated in PIP2 regulation of Kir channels. We discuss some important issues dealing with these topics.
This article has been cited by other articles:
![]() |
A. R. Mackie and K. L. Byron Cardiovascular KCNQ (Kv7) Potassium Channels: Physiological Regulators and New Targets for Therapeutic Intervention Mol. Pharmacol., November 1, 2008; 74(5): 1171 - 1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Liu, H. Liang, L. Liu, and H. Zhang Phosphatidylinositol 4,5-bisphosphate hydrolysis mediates histamine-induced KCNQ/M current inhibition Am J Physiol Cell Physiol, July 1, 2008; 295(1): C81 - C91. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Schuetz, S. Kumar, P. Poronnik, and D. J. Adams Regulation of the voltage-gated K+ channels KCNQ2/3 and KCNQ3/5 by serum- and glucocorticoid-regulated kinase-1 Am J Physiol Cell Physiol, July 1, 2008; 295(1): C73 - C80. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Brown Kv7 (KCNQ) potassium channels that are mutated in human diseases J. Physiol., April 1, 2008; 586(7): 1781 - 1783. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |